ClinicalTrials.govpublic full text
Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
oral squamous cell carcinoma (oscc), oropharyngeal squamous cell carcinoma, resectable oral and oropharyngeal squamous cell carcinoma, locally advanced oscc, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 876987
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.